Gsk

(Image: Getty/Anghi)

GSK gets first approval for two-drug HIV treatment

By Ben Hargreaves

GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.

Pharma appointments create controversy

Hired and Retired: Controversies at the top

By Ben Hargreaves

The new year has led to a new look to executive boards across the pharma industry, but the movement has arrived with a degree of intrigue in some cases.